Summary
Concentrations in cerebrospinal fluid (CSF) and plasma of bambuterol and its active metabolite, the β2-adrenoceptor agonist terbutaline, were measured in man after four once-daily doses of 30 mg bambuterol hydrochloride (Bambec®). Nine patients scheduled for orthopaedic surgery under spinal anaesthesia completed the study.
The concentrations of both substances were much lower in CSF than in plasma, the ratio CSF/plasma being 0.09 for bambuterol and 0.19 for terbutaline, at apparent steady state. While the rank order of the ratios was expected from the fractions of unbound bambuterol and terbutaline in plasma, their absolute values were only about 1/6 (bambuterol) and 1/4 (terbutaline) of those predicted from diffusion equilibria between plasma and CSF.
Thus, the rates of transport of bambuterol and terbutaline from plasma into the central nervous system appear to be slow relative to transport out of the system, e.g. by outflow of CSF. The findings are in agreement with animal experiments and suggest that bambuterol and terbutaline are less likely than lipophilic β2-adrenoceptor agonists to interact with central receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bodin NO, Hansson E, Ramsay CH, Ryrfeldt Å (1972) The tissue distribution of 3H-terbutaline (BricanylR) in mice. Acta Physiol Scand 84: 40–47
Caccia S, Fong MH (1983) Kinetics and distribution of the β-adrenergic agonist salbutamol in rat brain. J Pharm Pharmacol 36: 200–202
Collins JM, Dedrick RL (1983) Distributed model for drug delivery to CSF and brain tissue. Am J Physiol 245: R303-R310
Guyton AC (1986) The special fluid systems of the body — cerebrospinal, ocular, pleural, pericardial, peritoneal, and synovial. In: Dreibelbis D (ed) Textbook of medical physiology, Saunders, Philadelphia, pp 374–381
Jeppsson A-B, Löfdahl C-G, Waldeck B, Widmark E (1989) On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration. Pulm Pharmacol 2: 81–85
Kambam JR, Horton BF, Parris WCV, Hyman SA, Berman ML, Sastry BVR (1989) Pseudocholinesterase activity in human cerebrospinal fluid. Anesth Analg 68: 486–488
Kennedy BM, Blomgren A, Edholm LE, Roos C (1987) Quantitative determination of terbutaline in human plasma after administration of bambuterol using coupled columns and electrochemical detection. Chromatographia 24: 895–899
Kramer I, Klingspohr HJ (1974) Ganztierautoradiographische Untersuchungen über die Verteilung und die diaplazentare Passage von Fenoterol-hydrobromid (Th 1165a) an Ratten. Arzneimittelforschung 24: 1210–1213
Lindberg C, Jönsson S, Paulson J (1990) Determination of bambuterol, a prodrug of terbutaline, in plasma and urine by gas chromatography/mass spectrometry. Biomed Environ Mass Spectrom 19: 218–224
Reynolds JEF (ed) (1989) Martindale: the extra pharmacopoeia, 29th edn., Pharmaceutical Press, London
Morgan DJ, Paull JD, Richmond BH, Wilson-Evered E, Ziccone SP (1986) Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. Br J Clin Pharmacol 22: 587–593
Nyberg L (1984) Pharmacokinetic parameters of terbutaline in healthy man. An overview. Eur J Resp Dis 65 [Suppl 134]: 149–160
Nyberg L (1986) Pharmacokinetic properties of bambuterol in solution and tablet — basis for once-daily dosage in asthma. Acta Pharmacol Toxicol 59[Suppl 5]: 229
O'Donnell JM (1988) Behavioral consequences of activation of beta adrenergic receptors by clenbuterol: evidence for mediation by the central nervous system. Brain Res Bull 21: 491–497
Ryrfeldt Å, Ramsay CH (1984) Distribution of terbutaline. J Resp Disp 65[Suppl 134]: 63–72
Saux MC, Girault J, Bouquet S, Fourtillan JB, Courtois (1986) Étude comparative des distribution tissulaires de deux β-mimétiques: le clenbuterol et le salbutamol chez le chien. J Pharmacol (Paris) 17: 692–698
Svensson LÅ, Tunek A (1988) The design and bioactivation of presystemically stable prodrugs. Drug Metab Rev 19: 165–194
Tunek A, Lebin E, Svensson LÅ (1988) Hydrolysis of 3H-bambuterol, carbamate prodrug of terbutaline, in blood from humans and laboratory animals in vitro. Biochem Pharmacol 37: 3867–3876
Yamamoto I, Iwata K, Nakashima M (1985) Pharmacokinetics of plasma and urine clenbuterol in man, rat and rabbit. J Pharmacobiodyn 8: 385–391
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosberg, B., Schröder, C., Nyberg, L. et al. Bambuterol and terbutaline in human cerebrospinal fluid and plasma. Eur J Clin Pharmacol 45, 147–150 (1993). https://doi.org/10.1007/BF00315496
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315496